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Background: This review evaluated pain research in cystic ﬁbrosis (CF).
Methods: OVID MEDLINE, CINAHL, AMED, Web of Science, Pubmed, PsychINFO and PsychARTICLES were searched from January 1995–
December 2012 to locate papers assessing pain in CF. A proforma was used to record the rationale for the study, characteristics of the sample, pain
assessment tools, pain location, frequency and severity, treatment/self-management, coping and the impact on daily activities and quality of life.
Results: All studies (n = 13) were retrospective. Chest and abdominal pains were most commonly reported. Pain was negatively associated with
pulmonary exacerbations, quality of life and treatment adherence. Approximately 50% of patients do not consult their GP or CF team about pain,
with many patients reporting self-management.
Conclusion: A high incidence of pain is reported in CF although there is little standardization of CF pain measurement. The way forward is to
develop guidelines on how to assess pain and provide adequate treatment for pain in CF.
© 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic ﬁbrosis; Pain; Pain assessment; Treatment; Quality of life
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Over the past 10 years studies have shown that pain
assessment and pain treatment in Cystic Fibrosis (CF) are
important, especially as pain has been associated with survival
[1]. Pain reduces the quality of life of chronically ill patients and
may negatively impact the ability to participate in disease-related
daily care [2–4]. Consequently, the assessment and treatment of
pain are imperative [5,6].
This review aims to provide a critical overview of CF pain
research that focusses on pain assessment and the impact of pain.
Reviewing the CF pain literature in this context is crucial given
that little is known. The results should aid the measurement of
pain and its clinical management in CF. Important findings will
be highlighted to guide future research and clinical decision
making.
2. Methodology
2.1. Search Strategy
A literature search was undertaken independently by two of
the authors. The search was limited to full papers in the English
language that included the keywords ‘cystic fibrosis’ and ‘pain’
in the title, abstract or keywords. Databases were searched from
January 1995 to December 2012 and records identified: OVID
MEDLINE (35), CINAHL (39), AMED (12), Web of Science
(42), Pubmed (202), PsychINFO (5) and PsychARTICLES (0).
Papers were checked for duplicates and relevance to this review
resulting in 47 publications that were potentially eligible and
were subsequently screened on full text. Eligibility criteria were
defined as: papers assessing location, frequency, intensity or
duration of pain, well-being and pain, disease severity and pain.
Papers were excluded if they were editorials, reviews or
meta-analyses, described case studies or were based solely on
the clinical/pharmacological treatment of pain. A total of 13
papers met the eligibility criteria and were included in the
review. The references of these papers were screened for
additional relevant work but no further papers were identified.
Table 1 provides a concise overview of this information.
3. Results
3.1. Rationale and study design
The rationale for undertaking ‘pain research’ in CF has been
threefold. The available literature has focussed on 1. evaluationof the prevalence and characteristics (location, frequency/
duration, intensity) of pain; 2. evaluation of the impact of pain
on everyday life from both functional and HRQoL aspects; and 3.
evaluation of self-management and clinical pain management.
All studies were retrospective, although three studies subse-
quently assessed patients following either an intervention [15,17]
or during an exacerbation [3]. Two studies included the
investigation of procedural pain [11,13]. The distinction between
acute and chronic pain was made only by two studies [12,16].
The study populations were: children [11,12,17], adults
[3,4,9,14,15] or children, adolescents and adults [7,10,13,16].
The papers by Koh et al. [11] and Palermo et al. [12] reported
on the same sample of children and adolescents.
3.2. The patient communicating about pain
Patients with CF consulted a range of individuals regarding
their pain [4,9,11,16]. Approximately 50% of patients (or less)
consulted their CF team or their GP [4,9,13]; about a quarter
consulted relatives or friends [9] with many reporting ineffective
self-medication [13].
3.3. Pain assessment tools
Pain assessment typically involves documenting pain loca-
tion, frequency, intensity and often functional (dis)ability and
psychological/social factors by means of pain assessment
instruments. A description of the pain assessment tools that
authors employed is provided in Table 2. Studies have selected a
range of assessment tools to measure pain in CF. Many of these
have been developed by the authors themselves without validity
or reliability considerations. This approach is labour intensive for
researcher/clinicians and participants, but no single assessment
tool is available to measure all aspects of pain in CF. Even the
Brief Pain Inventory (a validated pain tool) is typically modified
to ensure CF specific content [3,14].
Apart from medical chart reporting [7] and nurse reports
(two nurses) [8], all assessment tools relied on the patient for
self-report. Children and adolescents completed the question-
naires themselves [10–13,16,17], except for one study where
parents reported for their children under the age of 8 [13].
Munck et al. [17] was the only study that employed a valid
definition of the pain they examined, namely recurrent abdominal
pain [18]. They subsequently found that only a minority of
children with CF truly presented with recurrent abdominal pain
andmost children reported abdominal discomfort. Those children
with severe pain reported a negative impact on their life.
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The main locations and prevalence of pain in patients with
CF are provided in Table 3. The literature points to a wide
variety of pain locations in single patients and to a wide range
in prevalence between studies.
3.5. Prevalence, frequency and duration of pain
It is difficult to establish the prevalence, frequency and
duration of pain in CF given that studies have applied different
definitions, time frames and assessment tools (see Tables 1 and
2). Nevertheless, all studies found that pain is frequently
reported by many patients. For example, Festini et al. [9] found
that 30% of adults suffered pain more than 10 times over a two
month period. Hubbard et al. [10] found that 10 out of 18 adult
patients reported daily pain. Lee et al. [15] reported that the
majority of adult patients had chronic pain for at least 3 months
prior to telling their primary physiotherapist.
3.6. Intensity of pain
Most studies administered intensity rating scales, but they
used different start and end points (e.g. 0–5 or 0–10)
[3,4,8,9,12–15]. Hayes et al. [4] found that about one third of
patients rated their pain 5 or higher out of 10. Kelemen et al. [3]
noted that pain ‘at its worst’ scored 4 (0–10). Kelemen et al. [3]
found no difference in average pain intensity or pain at its
worst between clinically stable patients and acutely ill patients.
Daily diary reporting (ranging from no pain to severe pain)
showed a highly individualised pattern of pain intensity in the 8
participating patients [17]. Epker et al. [8] found no significant
association between patient reports and nurses reports on the
perception of pain severity. The two nurses in this study
perceived patients to be in significantly more pain than did the
patients themselves.
3.7. Procedural pain
Koh et al. [11] noted that the majority of patients reported
mild procedural pain. A small number of the children and
adolescents in this study (n = 46) experienced severe pain from
blood draws (7%), peripherally inserted central catheter (PICC)
placements (9%), gastrostomy placements (8%) and throat
cultures (8%). In contrast, Sermet-Gaudelus et al. [13] reported
widespread procedural and anticipatory pain. Two-thirds of the
sample (n = 73 children and 110 adults) reported pain during
blood sampling, with a visual analogue score greater than six
(0–10) for one-third. Eighty-six percent of adults reported pain
during arterial blood gas taking. Anticipatory pain was reported
by 90% of the patients, with most expressing a preference for
topical anaesthetics to reduce needle-stick pain. Sixty percent
of the adults and 40% of the children with a totally intravenous
access device (TIVAD) reported pain during or just after the
placement procedure and 85% reported fearing the next TIVAD
placement. For bronchoscopy, 80% of children and 90% of the
adults reported pain during or just after the procedure.3.8. Disease severity and pain
Disease severity was broadly ‘defined’ in three ways: a. by
using FEV1% predicted; b. by means of medical descriptions,
such as ‘acute illness’, ‘pulmonary exacerbations’, or ‘end-of-life’
and c. by using the Shwachman Rating of Illness Severity (four
components: history/general activity level, pulmonary physical
findings and cough, nutritional status and chest X-ray findings).
No difference in pain reporting was observed when using
FEV1% predicted as a parameter of disease severity [13,14]. It
may be that FEV1% predicted is not a good single indicator to
use for disease severity in relation to pain [4]. For children, Koh
et al. [11] reported that children with chest pain, who were
found to have slightly reduced FEV1%, had more perceived
functional limitations as a result of their pain, but FEV1% was
not correlated with the frequency or severity of pain.
Increased intensity of pain was reported in the medical records
of patients who had more advanced lung disease (not specifically
defined); chest pain and headache increased significantly three
months prior to death [7]. Chest pain was also reported
specifically associated with acute exacerbations [3] and with an
increase in the number of pulmonary exacerbations (deterioration
of disease) and death [4,7].
Finally, Epker et al. [8] used the Shwachman Rating of
Illness scale but found that self-reported pain was correlated
only with history/general activity level.3.9. Well-being and pain
Well-being has been assessed using Cystic Fibrosis specific
Health Related Quality of Life scales (HRQoL) [3,4,12,17].
Kelemen et al. [3] found that pain predicted ratings on domains
of HRQoL, including physical functioning, social life, symp-
tom and treatment aspects, emotional response and school or
work. Kelemen et al. [3] also found that pain catastrophizing
was an important correlate to HRQoL. Pain catastrophizing is
defined as an exaggerated negative interpretation of pain, which
may occur during actual or anticipated painful experiences [19]
and provides valuable information about individual response to
and appraisal of pain. Certain locations of pain may be related
to different domains of HRQoL [4,12]. For example, children
with chest pain may be more at risk for depressed mood [12].
Other assessments of well-being included anxiety and
depression, for example the Hospital Anxiety and Depression
Scale [4] and general emotional well-being assessment tools,
for example the Emotional upset scale [11] or the McGill
Emotional Status [17]. Table 4 shows how pain is associated
with different aspects of well-being.3.10. Pain and interference with CF treatment
Most studies conclude that pain is related to the ability or
inability to perform CF treatment [3,4,8–13]. Several studies
reported an explicit interaction between pain and a restriction to
perform physiotherapy and exercise [3,4,11,13]. For example,
Sermet-Gaudelus et al. [13] found that 28% of the children and
Table 1
Concise overview of reviewed studies.
Author Rationale Sample Pain assessment/time
frame
Results (frequency, pain location, treatment/
self-management, impact on daily life/HRQoL)
Ravilly et al.,
1996 [7]
Examine clinical pain
management in relatively sick
patients
78 adults 58 deceased, mean
age at death = 26
23 alive, mean age 23
Mean FEV1 = 58%
Chart review
February 1986–October
1993
Frequency: All charts showed that patients reported
pain, 84% reported serious pain, especially towards
death.
Locations: chest, headache, back, limb, abdomen.
Management: N50% tried non pharmacological
approach (acupuncture, TENS, biofeedback); med-
ications: NSAID, tricyclic antidepressants, thoracic
epidural analgesia, opioids. Patients attended a pain
treatment centre.
Impact: not recorded
Epker et al.,
1999 [8]
Assessment of pain and pain
related impairment in adults with
Cystic Fibrosis
75 adults MPI Time frame not
specified
Frequency:65% reported pain severity of 2 or less,
24% reported no pain.
Locations: not recorded.
Management: not recorded.
Impact: 63% pain-related interference of 2 or less,
17,3% no interference; 38,7% reported an affective
distress score of 2 or less and 61,3% reported a score
of 3 or less. 60% reported a life control score of 4 or
more and 25,3% reported general activities of 4 or
greater.
Festini et al.,
2004 [9]
Evaluate prevalence of pain,
self-management and impact on
everyday life
239 adults
Mean age = 26
Mean FEV1 = 56%
Ad hoc questionnaire
Past 2 months
Frequency: 225/239 reported pain.
Location: headache, stomach, heartburn, backache,
bones/muscular pain, abdominal, chest.
Management: 24% homeopathic or
non-pharmacologic remedies; 91% took medicine,
not specified.
Impact: 63% unfavourable impact on daily activity.
Hubbard et al.,
2005 [10]
Investigate pain experiences,
disability and coping strategies
18 adults (12 female)
67 % older than 23 years of
age
Web-based questionnaire
Retrospective over
1 month
Frequency: 17/18 reported pain.
Location: chest, joints.
Management: preferred coping style is active and
accommodative (problem solving, resting,
distraction).
Impact: pain affected recreation, occupation, family/
home responsibility, sex behaviour, self-care.
Koh et al.,
2005 [11]
Assessment of acute and chronic
pain and pain management and
the relationship of pain with
disease severity
46 children and adolescents
Mean age 12.9
Mean FEV1 = 80%
Faces Pain scale
Body outline
VAS Retrospective over
1 month
Frequency: 46% reported pain at least once a week.
Majority reported mild procedural pain.
Location: abdominal/pelvic, chest, head/neck.
Management: rest, relaxation, heat or cold, family/
friends, distracting; medication: acetaminophen,
NSAID.
Impact: children with chest pain were at risk for
experiencing functional limitations and lower
FEV1%.
Palermo et al.,
2006 [12]
Assessment of pain and impact
on HRQoL
46 children and adolescents
Mean age 12.9
Mean FEV1 = 80%
Faces Pain scale Body
outline VAS
Retrospective over
1 month
Frequency: 46% experienced pain at least once a
week.
Location: abdominal/pelvic, chest, head/neck.
Management: not recorded.
Impact: pain was associated with decrements in
HRQoL across multiple domains.
Sermet-Gaudelus
et al., 2009 [13]
Assessment of pain prevalence,
symptoms and treatment.
Evaluation of the relationship
between pain, disease severity
and HRQoL
73 children,
Mean age 10.2
Mean FEV1 = 70%
110 adults
Mean age 28.5
Mean FEV1 = 50%
Ad hoc questionnaire
Body outline drawings
Retrospective over
1 month
Frequency: 59 % of children and 89% of adults
reported at least one episode of pain. 85% and 78%
reported procedural pain and anticipatory pain, more
frequent in severe disease.
Location: head, chest, abdominal (children N adults),
backache (adult N children), muscular ache
(child N adult).
Management: 40% of children and 50% of adults
reported use of analgesics: acetaminophen, NSAID,
aspirin, antispasmodic treatments, opioids.
Impact: 50% of children and 70% of adults reported
intense, long-lasting and recurrent pain episodes that
impacted their QoL.
426 T. Havermans et al. / Journal of Cystic Fibrosis 12 (2013) 423–430
Table 1 (continued)
Author Rationale Sample Pain assessment/time
frame
Results (frequency, pain location, treatment/
self-management, impact on daily life/HRQoL)
Flume et al., 2009
[14]
Association between pain and
sleep quality
50 adults
Mean age 31
Mean FEV1 = 58%
Brief Pain Inventory
Pittsburgh Sleep Quality
Index
Retrospective over
1 month
Frequency: 64% reported pain within last month.
Location: abdomen, back, chest, extremities, head and
neck.
Management: not recorded.
Impact: Pain is strongly correlated with
impaired sleep.
Lee et al.,
2009 [15]
To assess a single
musculoskeletal treatment
session to alleviate pain and ease
breathing
105 adults
Mean age 30.5
Mean FEV1 = 48.1%
Body outline drawings
Past 3 months
Frequency: 90% reported chronic pain.
Location: musculoskeletal pain.
Management: Improvement in ease of breathing was
achieved using a combined approach of manual
mobilization technique and massage therapy.
Impact: pain impacts airway clearance and exercises.
Stenekes et al.,
2009 [16]
To assess self-management of
pain, dyspnoea and cough
64 children and 59 adults,
Mean age 20 years
Ad hoc questionnaire
Retrospective over
1 month
Frequency: 84% reported pain.
Location: headache and abdominal pain.
Management: non-pharmacological (resting, doing
nothing, heat, cold); medication: acetaminophen,
NSAID, aspirin, antispasmodic treatments, opioids.
Impact: pain inhibited daily activity especially with
increasing severity of pain.
Hayes, 2011 [4] To assess the factors associated
with pain and its impact on
clinical outcome
83 patients
Median age 29
Median FEV1 = 64%
Brief Pain Inventory
Online Survey
Retrospective over
1 month
Frequency: 82% reported moderate to severe pain.
Location: head, sinuses, back, chest, abdomen, joints.
Management: not recorded
Impact: pain is associated low mood, poor HRQoL,
pulmonary exacerbations and death.
Kelemen et al.,
2011 [3]
Prevalence, severity and location
of pain. Psychosocial
consequences and impact on
HRQoL
73 adults
Mean age 30
FEV1 = 60%
Prospective study of 33
patients with acute
exacerbation
Body outline drawing
Brief Pain Inventory
Previous week
Frequency: 89% reported pain.
Location: head, neck, joints, chest.
Management: not recorded
Impact: pain interfered with airway clearance for
those with acute exacerbations and exercise
interventions. Pain was related to poorer physical
functioning, emotional status and greater interference
with CF treatment, including exercise.
Pain catastrophizing correlated with increasing pain.
Munck et al.,
2011 [17]
Prevalence of recurrent
abdominal pain its management
and impact on HRQoL
8 children
Mean age 14
Mean FEV1 = 85%
Faces Pain scale Eland
pain location Ad hoc
questionnaire
28 daily pain diary
Frequency: 8/130 patients fulfilled criteria for
recurrent abdominal pain.
Location: abdominal pain.
Management: behavioural interventions and
increasing pancreatic enzymes.
Impact: pain according to criteria has strong impact on
daily life.
FEV1 = Forced Expiratory Volume 1st second; MPI = Multidimensional Pain Inventory; TENS = Transcutaneous Electrical Nerve Stimulation; NSAID =
nonsteroidal anti-inflammatory medications; VAS = Visual Analogue Scale; HRQoL = Health Related Quality of life.
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preventative strategies were used to avoid the symptoms.
Hayes et al. [4] suggest that pain may lead to decreased
mechanical airway clearance, either because patients are in too
much pain to participate in airway clearance activities or
because the airway clearance treatment exacerbates their pain,
which can worsen infections and promote new ones.3.11. Pain management
Studies specifically examining the pharmacological treat-
ment of pain were excluded from this review. However, eight
studies did report on patients' management of their pain, which
will be described in two parts; namely a. the use of medication
to relieve the pain and b. other ways to relieve the pain. It is
acknowledged that this section may result in bias whendiscussing pain management, but it will provide a foundation
for future work in this area.
3.11.1. Medication use
Based on medical records, Ravilly et al. [7] noted that
nonsteroidal anti-inflammatory (NSAIDs) medications were
used as initial therapy for pain in the majority of patients. No
complications were recorded. With increasing illness, thoracic
epidural analgesia and opioids were prescribed. Constipation
was described as a complication of opioid use. Opioid dosing
over time did not suggest progressive dose escalation nor
tolerance in 9 out of 10 patients. Only one patient exhibited
signs of drug-seeking behaviour.
For children, Koh et al. [11] reported that those who were
given medication (especially those with head/neck pain) took
acetaminophen or NSAIDs, or a combination. None of the
children in this study took opioids for pain management. Hayes
Table 2
Pain assessment tools.
Assessment tool Studies employing
the tool
Description of tool
Medical Chart Review [7] Assessed pain location and frequency (note: authors defined headache and chest pain using standardized criteria).
Multidimensional Pain
Inventory
[8] Three sections: impact of pain on patients' lives, the response of significant others to the patients when they are in pain
and the extent to which patients participate in common daily activities.
5 scales were used: pain severity, interference, life control, affective distress and general activity level.
Faces Pain Scale [11,12] Pain severity: 7 faces (no pain–worst pain ever).
Pain frequency: 6 point scale (less than 1 month to daily).
Pain duration:4 point scale (less than 1 h to all day).
Pain bother: 5 point (not at all to very much).
Faces Pain Scale-revised [17] Assessed pain intensity for the episode that had caused the greatest pain.
Body Outline Drawings [11,12] Scored (pain/no pain) for 9 anatomical areas according to standardized body regions.
[13] Scored (pain/no pain) for several anatomical areas according to standardized body regions.
[15] Scored (pain/no pain) for several locations on the anterior and posterior view of a body outline.
[3] Scored (pain/no pain) for 45 anatomical areas according to standardized body regions.
Eland pain location [17] Children identify pain location on body drawing and use colour to indicate the intensity of the pain.
Daily Diaries [17] 28 day pain diary that assessed frequency, intensity, duration and management of pain.
Ad hoc questionnaires/
Interviews
[9] Structured questionnaire assessing pain location (9 regions), intensity (with 1 = mild to 10 = severe) and frequency of
pain, pain management and the negative consequences of pain on everyday life.
[11,12] Visual Analogue Scale, assessed activity limitation (0–10 point scale).
[13] Structured questionnaire assessing pain frequency (less than once a month to daily), pain intensity (VAS 0–10, no pain
to worst pain imaginable), duration (VAS 0–10, less than one hour to all day) and chronicity (recurrent or continuous
for more than 6 months). Impact of pain on daily life and CF treatment management.
[16] Structured questionnaire assessing duration of pain (headache, abdominal), dyspnoea and cough and self-management.
[17] Questions about how abdominal pain interfered with everyday activity (130 children). This information was used to
select patients for prospective pain evaluation (n = 8).
[10] Web-based questionnaire assessing pain intensity, duration and frequency.
Pain Disability Index [10] 7 items assessing how pain disrupts normal activities on a 0–10 point scale (no disruption to totally disrupted).
Brief Pain Inventory (BPI) [4] Frequency of pain in the past week/month.
Pain severity on a 0–10 point scale (no pain to bad as you can imagine).
Pain interference with 7 aspects of daily life (on a 0–10 point scale).
[14] Modified the BPI by including an item relating to the impact of pain on CF treatment management.
[3] Modified the BPI by adding 4 items relating to the impact of pain on cough, breathing, exercise and airway clearance.
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medications (acetaminophen, 43%; ibuprofen, 58%).
Sermet-Gaudelus et al. [13] provide a detailed account of the
drugs used by the patients in their sample. They found that 40%
of the children and 50% of the adults with pain reported using
analgesics. Acetaminophen was used most frequently (59%)
followed by NSAIDs (10%) and aspirin (5%). Abdominal pain
was treated mainly with antispasmodic treatment and increased
pancreatic enzymes. One patient in this study used opioids.
Frequency of treatment did not differ between the children and
the adults. Sixty-five percent of the children and 60% of the
adults reported significant relief after treatment whereas 25% of
the children and 10% of the adults reported either very limited
or no effectiveness.Table 3
Range of % of patients reporting pain according to locations.
Headache/sinus 25%–64%
Chest pain 16%–72%
Back pain 15%–70%
Gastrointestinal pain 10%–51%
Musculoskeletal pain 12%–61%Apart from Ravilly et al. [7] and Sermet-Gaudelus [13], the
reports did not describe duration of analgesic medication use
nor risk of drug dependence.
3.11.2. Other ways to relieve the pain
Some patients took no actions against their pain, possibly
because of high tolerance to pain or not wanting to increase their
treatment burden [9,11,13]. Nevertheless, many patients did take
some action to alleviate the pain, other than medication
[4,9,11,13,16,17]. These actions included homeopathic products
or non-pharmacological remedies (massages, acupuncture, herbal
remedies, physical activities, rest, heat or cold, distracting activ-
ities, yoga, meditation, self-hypnosis or osteopathy). Hubbard et
al. [10] studied the way patients coped with the pain and found
that patients preferred to use active and accommodative tech-
niques to cope with pain, including problem solving, resting, and
distraction.
Finally, Munck et al. [17] described two patients regularly
attending appointments with a pain management team which
successfully relieved pain as well as emotional upheaval, anxiety
and stress. Ravilly et al. [7] also reported successful follow up by
a pain treatment centre. Munck et al. [17] also found that in two
patients stopping the high intake of fizzy beverages and
optimizing pancreatic enzymes alleviated their abdominal pain.
Table 4
Pain and well-being.
Worse pain is associated with: Reference
More symptoms of anxiety and depression [4]
Poorer physical functioning [3,8–11,13,16]
Worse emotional status [3,4,8,11–14,17]
Impairment of sleep [12,13]
Impairment of exercise and work-related tasks [3,4,8–12]
Restriction on daily activities [4,8,13,16]
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Two studies evaluated a specific treatment for pain [15,17].
Lee et al. [15] studied the effect of manual mobilization
techniques and massage therapy on pain and improvement of
ease of breathing, both with positive results. Munck et al. [17]
identified children using a defined pain assessment score for
abdominal pain, the Apley definition [18] and set up an
individualized treatment plan for each child. The treatment
plans led to an improvement in pain reports. Both studies
advocate an individual approach to pain and pain management.
3.13. Limitation of studies
A main limitation of current CF pain research is that there is
little standardization in the pain measures used or the time
frame for assessing pain. The distinction between acute and
chronic pain was rarely used. The large variation in the
frequency of pain may be attributed to the differing definitions
of pain applied and time frames selected [3]. A further
limitation is the lack of control groups [15] to differentiate
between CF related pain and pain patients experience similar to
a non CF population. Also, the association between cough and
pain intensity has not been well addressed and little is known
about the association between health care use and pain
reporting. The latter is from a cost–benefit point of view
important. The studies evaluated patient reported medication
use and other ways to relieve pain, but limited data is available
on duration of analgesic medication use or risk of drug
dependence. Finally, Munck et al. [17] and Lee et al. [15]
demonstrated that short-term interventions were beneficial but
long-term studies are needed.
3.14. The way forward
This review highlights the importance of pain and pain
assessment in CF. A high incidence of pain is reported in CF
with evidence that pain is negatively associated with performing
physiotherapy and exercise [4,11,13], pulmonary exacerbations
[3,4,7], quality of life [3,4,12] and survival [1]. It has been
suggested that pain may be an important marker of inflammation
and ‘disease activity’ although evidence is lacking to corroborate
this [4,7]. The relationship between pain and FEV1% predicted
remains unclear [11]. This stimulates the discussion about whether
there is increased (chest) pain due to more advanced disease, or
whether reduced lung function (assessed by FEV1% predicted)
results from a higher level of chest pain. In relation to this, futureresearch should investigate the association between cough and pain
intensity and the differentiation between acute and chronic pain in
CF. A prospective study on pain in CF is urgently required.
The way forward would seem to be the integration of pain
assessment in the CF clinic [16]. Given that half of people with
CF do not communicate with their physician about their pain it
is crucial to make pain assessment and management part of the
care plan. This would also clarify the association between
patients' health care use and prevalence of pain.
We face the challenge of developing a standardised, valid
and reliable pain assessment for CF together with appropriate
treatment plans/guidelines on how to deal with pain in CF.
Efficient pain management will improve patients HRQoL and
help patients to perform essential interventions and treatments
that prevent early deterioration.Appendix A. Supplementary data
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.jcf.2013.04.001.References
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